The rat
T HE PLACENTA acts as a multiple function organ in the maintenance of pregnancy and in fetal growth. Rat placenta produces several members of the placental PRL family that show structural similarities to pituitary PRL. To date, nine members of the placental PRL family have been cloned, and they are categorized into two subfamilies according to their structure and function (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) ; the placental lactogen (PL) subfamily and the PRL-like protein (PLP) subfamily. Expression of these molecules is pregnancy stage specific and is strictly regulated by autocrine or paracrine factors as well as extraembryonic signals (12, 13) . Therefore, these proteins are not only excellent markers of placental function, but they may also be key molecules involved in regulating pregnancy.
PRL exerts its biological function through the PRL receptor; when PRL is bound to the receptor, Janus kinase-2 (JAK2) and signal transducer and activator of transcription-5 (STAT5) are activated by tyrosine phosphorylation (14, 15) . Activated JAK2 and STAT5 play important roles in cytokinedependent cell growth and differentiation (14, 16, 17) . PL subfamily members, including PL-I, PL-II, and PL-Iv, are also able to bind to the PRL receptor and to stimulate the proliferation of Nb2 cells (18 -20) . The PLP subfamily includes PLP-A, PLP-B, PLP-C, PLP-D, PLP-Cv, and decidual PRLrelated protein (dPRP). Of these, PLP-A, PLP-B, PLP-C, and dPRP do not bind to the PRL receptor (21) (22) (23) (24) nor do they stimulate lactogenic activity, even though they are structurally similar to PRL (13, 25) . On the other hand, Jackson et al. (26) reported that proliferin and proliferin-related protein, which are members of the mouse placental PRL family, have the ability to regulate angiogenesis, which indicates that PLPs have nonlactogenic activities. Within the PLP subfamily, PLP-C, PLP-Cv, PLP-D, and dPRP are highly homologous, and their gene expression patterns are similar, except for that of dPRP (7) (8) (9) (10) .
N-Glycosylation is another feature of placental PRL family members, except for PL-II (2) . The glycosylation of PLs and PLPs has been investigated, and most of them were found to be glycosylated (9, 18, 20, 22, 27, 28) . We have investigated the role of the N-linked sugar chain of PL-I on Nb2 proliferation and discussed its importance in signal transduction (29) . On the other hand, it has been reported that the N-linked sugar chain reduces porcine PRL activity, as measured by Nb2 assay or receptor binding assay (30) . Another report showed little contribution by the sugar chains of PL-I to its biological activity (18) . We have recently cloned another PLP-related complementary DNA (cDNA) by the differential display method and tentatively named the gene product PLP-H. In this paper we describe the molecular cloning of this newly identified molecule and the characterization of its expression in both tissues and Rcho-1 cells. To analyze its biological function, we made a recombinant protein for PLP-H together with PLP-D and examined whether the signal is transduced through the PRL receptors.
Materials and Methods Reagents
The 5Ј-rapid amplification of cDNA ends (5Ј-RACE) system and Fischer's medium were purchased from Life Technologies (Grand Island, NY). The pGEM T vector system was purchased from Promega Corp. (Madison, WI). Isogen was purchased from Nippon Gene (Toyama, Japan). TaKaRa EX Taq polymerase and restriction endonucleases were purchased from Takara Shuzo (Kyoto, Japan). The digoxygenin (DIG) RNA labeling kit, the DIG nucleotide detection kit, CDPStar, and peptide-N-glycosidase F were purchased from Boehringer Mannheim Yamanouchi (Tokyo, Japan). The AutoRead sequencing kit and protein A-Sepharose were purchased from Pharmacia LKB (Uppsala, Sweden). Synthetic oligonucleotide primers were purchased from Grainer Japan (Tokyo, Japan). FBS was purchased from JRH Biosciences (Lenexa, KS). Donor horse serum was obtained from Summit Biotechnology (Ft. Collins, CO). Monoclonal antiphosphotyrosine antibody (4G10) and anti-JAK2 antiserum were purchased from Upstate Biotechnology (Lake Placid, NY). Anti-STAT5 antiserum was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Ovine PRL (oPRL; NIDDK oPRL-20) was provided by the U.S. National Hormone Pituitary Program. Unless otherwise noted, all other chemicals and reagents were purchased from Wako Pure Chemicals (Osaka, Japan).
Animal treatment and tissue preparation
Wistar rats were purchased from the Imamichi Institute for Animal Reproduction (Ibaraki, Japan). Sprague-Dawley, Fisher, and Lewis rats were purchased from Charles River (Ibaraki, Japan). Rats were kept under a lighting schedule of 14 h of light (lights on at 0500 h) and 10 h of darkness (lights off at 1900 h) and were allowed food and water ad libitum. Timed pregnancies and tissue dissections were performed as previously described (8) .
Placentas collected for in situ hybridization were embedded in OCT compound (Miles, Inc., Elkhart, IN), quickly frozen in ice-cold ethanol, and stored at Ϫ80 C until use.
Molecular cloning of PLP-H cDNA and sequence analysis
In a series of experiments exploring a stage-specific placental factor by differential display (8, 31), we obtained a cDNA fragment encoding a late pregnancy-specific messenger RNA (mRNA), and we cloned the full-length cDNA using 5Ј-RACE and full-length PCR as previously described (8) . The products of full-length PCR were ligated into the pGEM T vector. The DNA sequence was determined for both strands by the dideoxy chain termination method using a sequencing kit (AutoRead) and a DNA sequencer (A. L. F. sequencer, Pharmacia LKB) (32) . Sequence analysis showed that this cDNA encodes a novel protein, which we tentatively named PLP-H.
RT-PCR analysis
First strand cDNAs for various tissues (kidney, liver, spleen, brain, ovary, fetus, and placenta) were prepared from total RNAs using RT (SuperScript, Life Technologies) and a (deoxythymidine) 15 -adaptor primer [5Ј-GAATTCTCGAGTCGACCCGGG-(T) 15 -3Ј]. 5Ј-Primers specific for PLP-C (5Ј-GCTGCTGGGACCCCCTCCG-3Ј; nucleotides 133-152), PLP-D (5Ј-GCTGCTGGAACCCCCTTGT-3Ј; nucleotides 177-195), and PLP-H (5Ј-ACTGCTGGGACCTCTCCA-3Ј; nucleotides 180 -198) were constructed and tested for the ability to specifically amplify each clone by PCR. Each template (PLP-C, PLP-D, and PLP-H) used for PCR contains full-length cDNA and the adaptor primer-binding site at the 3Ј-end. The PCR was performed with the 5Ј-specific primer, adaptor primer, the template, and TaKaRa EX Taq polymerase. The PCR conditions for denaturation, annealing, and elongation were 95, 65, and 72 C for 30 sec, 30 sec, and 1 min, respectively. Then, the RT-PCR was performed using an adaptor primer and a series of 5Ј-primers specific for each clone with the PCR condition stated above.
Cell lines
The Rcho-1 cell line was a gift from Dr. Michael J. Soares (University of Kansas Medical Center, Kansas City, KS). These cells were cultured and induced to differentiate as previously described (8) . The COS-7 cell line was purchased from RIKEN Gene Bank (Ibaraki, Japan). The Nb2 cell line was provided by Dr. Peter W. Gout (British Columbia Cancer Research Center, Vancouver, Canada) (33) .
Northern blot analysis
DIG-labeled riboprobes were synthesized using T7 polymerase as previously described (8) .
For the Northern blot analysis, total RNA dissolved in electrophoresis buffer [20 mm 3-(N-morpholino)-propanesulfonic acid (pH 7.0), 5 mm sodium acetate, and 1 mm EDTA] containing 50% formamide and 6.5% formaldehyde was heated to 65 C for 15 min, electrophoresed on a 1.0% agarose-formamide gel, and transferred to a nylon membrane (Hybond-N, Amersham, Tokyo, Japan). The membrane was hybridized with a DIG-labeled complementary RNA (cRNA) probe in 5 ϫ SSC (standard saline citrate) containing 50% formamide, 1.5% SDS, and 1% blocking reagent (Boehringer Mannheim Yamanouchi), washed twice with 2 ϫ SSC-0.1% SDS at 25 C for 5 min, and then washed twice with 0.1 ϫ SSC-0.1% SDS at 68 C for 1 h. The membrane was incubated in blocking buffer (1% blocking reagent and 150 mm NaCl in 100 mm maleic acid, pH 7.5) at 25 C for 1 h, followed by the addition of anti-DIG antibody (1:10,000 dilution). The membrane was washed three times with TBS-Tween (0.3%) for 5 min each time and finally rinsed in 100 mm Tris-HCl (pH 9.5) with 100 mm NaCl. The chemiluminescent reaction was performed in the latter solution containing CDP-Star reagent (1:100 dilution; Boehringer Mannheim Yamanouchi), and the membrane was exposed to x-ray film for 30 min.
In situ hybridization
In situ hybridization for detecting PLP-H was performed as previously described (8) using the PLP-H cRNA probes made for Northern blot analysis. Finally, the tissue sections were colored with nitroblue tetrazolium salt (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP), and counterstained with either hematoxylin or methyl green.
Generation and purification of recombinant proteins
Sets of primers were generated for PLP-H, PLP-D, and PL-I excluding the signal sequences, and PCR reactions were performed. The PCR products were digested with EcoRI and KpnI restriction enzymes and ligated into the pSR␣-CHFX vector (a gift from Dr. A. Miyajima), which encodes the CD8␣ signal peptide, followed by both Flag and histidine epitope tags to generate N-terminus-tagged proteins (34) . These plasmid were transfected into COS-7 cells by the diethylaminoethyl-dextran method (35) . Four days after transfection, the culture media were collected, and the proteins were purified using Ni ϩ -nitrilo-triacetic acid resin (Qiagen, Chatsworth, CA) and anti-Flag M2 affinity resin (Eastman Kodak Co., New Haven, CT) according to the manufacturer's instructions. Purified proteins were quantitated using the BCA microassay kit (Pierce Chemical Co., Rockford, IL). The purity of these proteins was checked by SDS-PAGE (10%) followed by silver staining.
Glycosidase digestion
The purified proteins were subjected to N-glycosidase F (Boehringer Mannheim Yamanouchi) treatment to remove N-linked sugar chains, as described previously (29) . In brief, partially purified proteins (1 g eluents from Ni ϩ -nitrilo-triacetic acid resin) were boiled for 5 min in denaturing buffer (0.5% SDS, 0.05 m EDTA, and 0.3% ␤-mercaptoethanol). Then the mixture was incubated at 37 C for 18 h in reaction buffer (0.02 U/l N-glycosidase F, 0.17% SDS, 1.25% Nonidet P-40, and 20 mm sodium phosphate, pH 7.5) and subjected to SDS-PAGE followed by silver staining and Western blotting using the anti-Flag antibody.
Immunoprecipitation and immunoblotting
Nb2 cells were starved in serum-free medium (Fischer's medium) for 5 h, then treated for 10 min with recombinant PL-I (100 ng/ml), PLP-H (1000 ng/ml), or native oPRL (100 ng/ml) at 25 C. Then 400 g whole cell extracts made in lysis buffer [20 mm Tris-HCl (pH 7.4), 150 mm NaCl, 1 mm sodium orthovanadate, 1 mm phenylmethylsulfonylfluoride, 50 mm sodium fluoride, and 1% Triton X-100] were incubated with antibodies to JAK2 for 1 h at 4 C, followed by incubation with protein A-Sepharose beads for 1 h at 4 C. The immunoprecipitates and supernatants were separated by centrifugation, and the supernatants were used for precipitating STAT5 by the same procedure, except that the antibody to STAT5 was used. Then the immunoprecipitates were washed three times with wash buffer (0.1 mm sodium orthovanadate   FIG. 1 . A, Nucleotide and predicted amino acid sequences of PLP-H. Translation was assumed to begin at the first ATG (nucleotides 59 -61) and to continue to the termination codon TAA (nucleotides 776 -778). A vertical arrow indicates the signal-peptide cleavage site. Putative glycosylation sites are boxed, and cysteine residues are circled. The polyadenylation signal sequence is underlined. B, Homology comparison of the rat PLP subfamily members that are highly homologous to PLP-H. and 0.5% Triton X-100 in PBS) and subjected to SDS-PAGE (10%) under reducing conditions. Proteins were transferred to a polyvinylidene difluoride membrane and blotted with antiphosphotyrosine monoclonal antibody (4G10). The levels of immunoprecipitated JAK2 and STAT5 were examined by reprobing the membranes with specific antisera.
Proliferation assays
The Nb2 proliferation assay was performed as previously described (36) . Briefly, Nb2 cells in growth medium (Fischer's medium containing 10% FBS and 10% horse serum) were transferred to 1% FBS and 10% horse serum in Fischer's medium, incubated for 24 h, collected, and washed three times in serum-free Fischer's medium. Then cells were divided into 96-well plates with 15,000 cells/well. Various concentrations of histidine-Flag-tagged recombinant PLP-H, PLP-D, PL-I, or native oPRL (NIDDK oPRL-20) were added. After 72 h at 37 C, the number of cells in each well was determined using a colorimetric cell counting kit that can measure the mitochondrial dehydrogenase activity (Dojindo Laboratories, Kumamoto, Japan) (37) . In brief, a mixture of 4-[6-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene sulfonate (Wst-1; 5 mm) and 1-methoxy-5-methylphenazinium methosulfate (0.2 mm) was added to each well (10 l/well), and the cells were incubated at 37 C for 4 h. Then, the absorbance at 450 nm was determined using an enyzme-linked immunosorbent assay plate reader. Values are presented as the mean Ϯ sem of triplicate samples, and similar results were obtained from three individual experiments.
Results

Cloning of PLP-H cDNA
We have cloned a cDNA fragment that was differentially expressed from rat placenta and have determined the full length of the cDNA by 5Ј-RACE. Then the full-length cDNA, of approximately 1 kb, was obtained by PCR using a 3Ј-adaptor primer and a 5Ј-primer to the 5Ј untranslated region, as described in Materials and Methods. The clone contained an open reading frame of 717 bp encoding 239 amino acids (Fig.  1A) . The termination codon was TAA at nucleotides 776 -778. A polyadenylation signal (38) at nucleotides 894 -900 and a polyadenylase tail were present in the 3Ј-noncoding region. There were two potential N-glycosylation sites, Asn-Leu-Ser and Asn-Asp-Thr, at amino acid positions 180 -183 and 188 -191, respectively. This newly identified clone showed considerable homology with previously identified members of the rat placental PRL family, especially PLP-C and PLP-D (78% and 67% amino acid sequence homologies, respectively; Fig. 1B) .
RT-PCR analysis of the tissue distribution and expression of PLP-H in other strains of rat
To distinguish PLP-H from PLP-C and PLP-D, we first designed the primers to specifically amplify each gene ( Fig.  2A) . DNA fragments corresponding to PLP-C, PLP-D, and PLP-H were specifically amplified using the set of primers described in Materials and Methods. Other than the target molecules, no amplification of other clones was detected. RT-PCR was then performed using these primers and first strand cDNAs from various tissues of Wistar rats and placentas from various rat strains (Fig. 2B) . PLP-H expression was seen only in the placenta, but it was present in every strain of rat examined. Two other related genes, PLP-C and PLP-D, were also expressed in each strain of rat examined (Fig. 2C) . This RT-PCR expression assay was also able to discriminate PLP-H from PLP-Cv (data not shown).
PLP-H expression in placenta and Rcho-1 cells
Northern blot analysis showed a 1-kb mRNA species hybridized with the PLP-H cRNA probe (Fig. 3A) . PLP-H mRNA was not detected on day 12, but was first detected on day 14, and its expression level increased from then until day 20, which is just before term.
Next, we analyzed PLP-H mRNA expression in a rat choriocarcinoma cell line, Rcho-1 (Fig. 3) . Total RNA obtained from Rcho-1 cells at each proliferation and differentiation stage was individually subjected to Northern blot analysis. The signal was detected 8 days after differentiation (Fig. 3B) . Glyceraldehyde-3-phosphate dehydrogenase was used as an internal control.
Cellular localization of PLP-H mRNA
In situ hybridization analysis of PLP-H expression showed that in day 20 placenta, PLP-H mRNA was specifically and predominantly localized to spongiotrophoblast and tropho- blast giant cells (TGC) of the junctional zone (Fig. 4, A and  B) . No expression of PLP-H mRNA was detected in day 12 placenta (data not shown). Incubation with sense RNA probes failed to show any specific hybridization to adjacent sections of day 20 placenta (Fig. 4C) . The results of in situ hybridization were consistent with those of Northern blot analysis as described above.
Recombinant PLP-H expression and purification
PLP-H, PLP-D, and PL-I were transiently expressed in COS-7 cells. From 1 liter conditioned medium, 200 -400 g of each protein were purified using two different affinity columns as described in Materials and Methods and Fig. 5A . To measure the purity of these proteins, they were subjected to SDS-PAGE followed by silver staining (Fig. 5D) . One major (lower) band and one minor (upper) band were detected for each protein. After treatment with N-glycosidase F, the minor band disappeared (Fig. 5, B and C) , suggesting that the minor portions of the recombinant proteins were glycosylated forms.
Signal transduction via PRL receptor and proliferation assay using Nb2 lymphoma cells
To examine whether PLP-H activates a PRL receptormediated signaling pathway, ligand-dependent JAK2 and STAT5 phosphorylation was analyzed. Immunoblotting analysis of subcellular extracts prepared from Nb2 cells stimulated with PLP-H, PL-I, or oPRL revealed that PLP-H did not induce PRL receptor-mediated JAK2 and STAT5 phosphorylation (or activation), whereas tyrosine phosphorylation of both molecules was seen after PL-I or oPRL stimulation (Fig. 6A) .
To further examine whether PLP-H together with PLP-D have PRL-like proliferative activity on Nb2 cells, the purified recombinant proteins were added to the culture medium at various concentrations, and after 72 h cells were counted by Wst-1 assay. oPRL and recombinant PL-I were also examined   FIG. 3 . Stage-and cell-specific expression of PLP-H. Northern blot analysis was performed using a PLP-H cRNA probe. A, Total RNA (20 g) isolated from placentas on days 12, 14, 16, 18, and 20 was separated on a 1% agarose gel, blotted onto a nylon membrane, and hybridized with digoxygenin-labeled PLP-H cRNA probe. The probe hybridized to a 1.0-kb mRNA. PLP-H expression was first detected on day 14 and increased as pregnancy proceeded. Lanes M and F represent the total RNA from male and female rat livers, respectively. B, Expression of PLP-H by differentiated Rcho-1 cells. Total RNA (10 g) isolated from undifferentiated (U) or differentiated (D1 and D8, 1 day and 8 days after the differentiation stimuli, respectively) Rcho-1 cells was examined for PLP-H expression using digoxygenin-labeled PLP-H cRNA probe as described above. Glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was the internal control. as positive controls. As shown in Fig. 6B , no PRL-like proliferative activity was seen for PLP-H and PLP-D, whereas both PL-I and oPRL stimulated proliferation dose dependently.
Discussion
We have cloned a new rat PRL-like molecule, PLP-H, which is highly homologous to PLP-C, PLP-Cv, and PLP-D. Nucleotide comparison shows that the similarity of PLP-H to these three related molecules is more than 80%. Among these molecules, PLP-H is most similar to PLP-C (91% nucleotide homology). To address whether these various molecules are conserved between rat strains, RT-PCR was performed to identify the molecules expressed in each strain of rat. The results showed that PLP-H together with PLP-C and PLP-D were expressed in all of the rat strains examined, indicating these molecules are not strain specific but are commonly expressed throughout the strains.
PLP-H expression was first detected on day 14, and the level of its expression increased during pregnancy, similar to the expression patterns of PLP-C, PLP-Cv, and PLP-D (7, 10, 8) . The cell types that expressed PLP-H were the spongiotrophoblast cells and the secondary TGCs, both of which express PLP-C, PLP-Cv, and PLP-D. These cell types are located at the maternal interface, which is called the junctional zone of the placenta. Rcho-1, a rat choriocarcinoma cell line, the lineage of which is thought to be TGC, expresses various placental PRL family proteins depending on the cell's stage of differentiation (39, 40) . Our data showed that PLP-H was expressed by Rcho-1 cells only after they had differentiated, confirming that TGC express PLP-H.
The placental PRL family members have been searched for both proteins and genes. Ogilvie et al. (41) sequenced four GH-like proteins secreted from placental explants that we now consider the glycosylated and nonglycosylated forms of PLP-C (7, 42), PLP-D (8) , and an uncharacterized protein. The amino acid sequence we deduced from the PLP-H cDNA exactly matches the 37 N-terminal amino acids of the uncharacterized protein they reported (41). Therefore, PLP-H is probably a secretory protein, and it may exist in the maternal and fetal circulatory system or in the extraplacental space.
To characterize the functions of PLP-H and PLP-D, we prepared a recombinant protein for each of them using the COS-7 transfection system. Purified PLP-H and PLP-D expressed in COS-7 cells both had two populations analyzed by SDS-PAGE and Western blotting. The upper minor bands (29 and 31 kDa, respectively) were probably the N-glycosylated forms of PLP-H and PLP-D, respectively, as these bands disappeared after N-glycosidase F treatment. The low frequency of glycosylation of PLP-H and PLP-D seems to be protein specific, as PL-I expressed in COS-7 cells is heavily glycosylated (29) . There are some indications of the role of N-linked sugar chains in the placental PRL family. Recently, Manzella et al. (43) reported that the N-linked sugar chains of these PRL family proteins are developmentally regulated. We examined the role of the N-linked sugar chain of PL-I by site-directed mutagenesis, and they demonstrated that it is involved in signal transduction through the PRL receptor, using the Nb2 proliferation assay and RRA (29) . As PLP-H and PLP-D are structurally similar to PRL and are glycosylated, we examined their lactogenic activity using the PRL-dependent Nb2 cell line. However, we did not detect signal transduction through the PRL receptor (JAK2 and STAT5 phosphorylation), and we did not observe Nb2 cell proliferation. PLP-H is most similar to PLP-C, PLP-Cv, PLP-D, and dPRP within the PLP subfamilies. The N-and C-terminal regions that are reported to be important for rat PRL biological function (44, 45) are not conserved in PLP subfamilies. These data show that PLP-H does not have lactogenic activities like the other PLP proteins (21) (22) (23) (24) .
The functions of PLP-H and the other PLP subfamily members remain to be elucidated; however, the site-and stagespecific expression patterns and the variations between the related molecules suggest that they may have unique biological actions. Therefore, it is likely that the PLP family has an unknown role and that the molecules in this family function through receptors specific for them. Further studies are now underway using the recombinant PLP-H (and PLP-D) made in this study to elucidate the roles of these molecules.
In conclusion, we have identified PLP-H in rat placenta, which produces at least 10 members of the PRL family. The molecular structure, expression pattern, and effect on PRL- 
